Tyra Biosciences
TYRA
95 hedge funds and large institutions have $1.11B invested in Tyra Biosciences in 2024 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 30 increasing their positions, 20 reducing their positions, and 8 closing their positions.
31,812% more call options, than puts
Call options by funds: $8.3M | Put options by funds: $26K
200% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 8
60% more funds holding in top 10
Funds holding in top 10: 5 → 8 (+3)
50% more repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 20
48% more capital invested
Capital invested by funds: $749M → $1.11B (+$357M)
20% more funds holding
Funds holding: 79 → 95 (+16)
0% less ownership
Funds ownership: 89.1% → 89.1% (-0%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
United Kingdom
|
+$22.4M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
+$4.2M |
| 3 |
TCM
Tang Capital Management
San Diego,
California
|
+$2.26M |
| 4 |
BlackRock
New York
|
+$2.04M |
| 5 |
Walleye Capital
New York
|
+$2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
-$10.4M |
| 2 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$5.96M |
| 3 |
SCM
Sio Capital Management
New York
|
-$4.19M |
| 4 |
ECM
ExodusPoint Capital Management
New York
|
-$2.73M |
| 5 |
American Century Companies
Kansas City,
Missouri
|
-$2.67M |
TYRA Hedge Fund Activity: Q3 2024 in Review
95 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Tyra Biosciences (TYRA) for Q3 2024, worth a combined $1.11B — up 48% from $749M a quarter earlier.
Buyers outnumbered sellers: 24 funds opened new TYRA positions and 8 closed out — a net gain of 16 holders — while 30 added to existing stakes and 20 trimmed.
The largest buyer was Janus Henderson Group, opening a new position worth an estimated $22.4M. The largest seller was Perceptive Advisors, cutting an estimated $10.4M.
- 95 institutional investors held Tyra Biosciences (TYRA) as of Q3 2024, up from 79 in Q2 2024.
- Funds reported $1.11B of Tyra Biosciences stock for Q3 2024, up 48% quarter-over-quarter.
- 24 funds opened new Tyra Biosciences positions in Q3 2024 and 8 closed out, a net change of +16 holders.
- The largest Tyra Biosciences buyer in Q3 2024 was Janus Henderson Group, an estimated $22.4M added.
- The largest Tyra Biosciences seller in Q3 2024 was Perceptive Advisors, an estimated $10.4M sold.
Based on aggregated 13F filings for Q3 2024.